000			03088nam a2200241uu 4500
001			372
003			OSt
005			20250213180606.0
008			001010s1995 xx ||||g| |0|| 0 eng d
090			_a5.02 _bV2156v
245	1	0	_aValuing health care : _bcosts, benefits, and effectiveness of pharmaceuticals and other medical technologies
260			_aCambridge : _bCambridge University, _c1995
300			_a273 p.
505	8	0	_tIntroduction _tMajor objectives of this book _tWaht is cost-effectiveness/cost-benefit analysis ? _tChapter plan _tDescription of specific chapters _t2 - Evidence of effectviness: evaluating is quality _tNature of the evidence _tQuality of the evidence _tExtensions of effectiveness evidence required for estimation of cost-effectiveness _tSummary _t3 - Utility assessment for estimating quality-adjusted life years _tConceptual framework _tThe concept of relative importance _tThe concept of utility _tMethods for assessing utility _tPsychological versus economic models _tCognitive limitations _tWhose preferences should be used in the model ? _tFixed versus variable preference models _tApplication and criticism: the Oregon experiment _tSummary _t4 - Measuring costs _tIdeals and realities in cost measurement _tPractice advice for measuring costs _tsummary _t5 - From cost-effectiveness ratios to resource allocation: where to draw the line ? _tThe basic cost-effectiveness model _tCost-effectiveness ratios form different perspectives _tIncremental cost-effectiveness analysis _tDetermining a critical ratio _tCost-benefit or cost-effectiveness analysis ? _tConclusion _t6 - Valuing health care benefits in money terms _tStandards and definitions _tThe need and settigns for analysis _tWhat difference does money make ? _tMeasuring benefits _tProblems with willingness-to-pay measures _tInsurance and cost-benefit analysis _tConclusion _t7 - Discounting health effects for medical decisions _tThe rationale for discounting _tProblems with the failure to discounting health effects for medical decisions _tThe rationale for discouting _tProblems with the failure to discount _tDiscounting and medical decisions under uncertainly _tModeling and estimating rates of discount for health _tConclusion _t8 - Statistical issues in cost-effectiveness contexts with biased risk perceptions _t8 - Statistical issues in cost-effectiveness analyses _tEstimation issues _tProblems in using administrativeness analysis _tConclusion _t9 - Decision trees and Markov models in cost-effectiveness research _tDecision trees _tModeling long-term consequences _tAppendix: further reading _t10 - The use of cost-effectiveness/cost-benefit analysis in actual decision making: current status and prospects _tCurrent applications of cost-effectiveness/cost-effectiveness/cost-benefit analysis in health policymaking _tA brief research agenda
650		4	_912122 _aPolítica de Saúde
650		4	_912964 _aCusto-Benefício
650		4	_912703 _aEficácia
650		4	_912404 _a Tomada de Decisão
942			_cG
998			_a20001010 _bElda R _cElda Raphael
998			_a20160310 _b1048^b _cLarissa
999			_aConvertido do Formato PHL _bPHL2MARC21 1.1 _c561 _d561
700			_a
041			_aeng